Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials
Open Access
- 30 September 2004
- journal article
- research article
- Published by Elsevier BV in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 128 (3), 442-448
- https://doi.org/10.1016/j.jtcvs.2004.03.041
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Stroke after cardiac surgery: a retrospective analysis of the effect of aprotinin dosing regimensThe Annals of Thoracic Surgery, 2003
- Aspirin and Mortality from Coronary Bypass SurgeryNew England Journal of Medicine, 2002
- Intraoperative treatment strategy to reduce the incidence of postcardiopulmonary bypass atrial fibrillation.Perfusion, 2002
- Pharmacological strategies for blood loss.The Lancet, 2001
- Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpointsThe Lancet, 1999
- Analyses of coronary graft patency after aprotinin use: Results from the international multicenter aprotinin graft patency experience (IMAGE) trialThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose RegimensThe Annals of Thoracic Surgery, 1996
- EditorialThe Annals of Thoracic Surgery, 1996
- A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass GraftingCirculation, 1995
- Aprotinin therapy for reoperative myocardial revascularization: A placebo-controlled studyThe Annals of Thoracic Surgery, 1992